Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)

Part of paid clinical trials in The Bronx, New York.

Sponsor
University Hospital of Cologne
Study ID
NCT06911099
Status
Recruiting
Apply to this trial

Conditions

  • Atrial Functional Mitral Regurgitation
  • Mitral Insufficiency

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This investigator-initiated, multicenter, international, retrospective registry aims to investigate outcomes of patients with atrial functional mitral regurgitation, as treated in clinical routine.

Key Dates

Start date
Jan 1, 2010
Status verified
Apr 2025
Primary completion
Dec 31, 2030
Completion
Dec 31, 2035

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER)
    Patients who underwent mitral valve transcatheter edge-to-edge repair. All devices may be included.
  • Arm: Guideline Directed Medical Therapy
    Patients who underwent conservative management with guideline directed medical therapy.
  • Arm: Transcatheter Mitral Valve Replacement (TMVR)
    Patients who underwent transcatheter mitral valve replacement. All devices may be included.

Primary Outcome Measure

Composite of all-cause mortality and heart-failure related rehospitalitzation [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Montefiore Medical CenterThe BronxNew York-
Azeem Latib, MD
[email protected]
(718) 920-4212
Andrea Scotti, MD
[email protected]

Find similar trials in The Bronx, NY

By research site
Montefiore Medical Center· The Bronx, NY

Related Studies